| Corixa is a developer of immunotherapeutics
with a commitment to treating and preventing autoimmune diseases,
cancer and infectious diseases by understanding and directing
the immune system. Corixa currently has multiple programs in
clinical development. Corixa was founded in 1994 and is headquartered
in Seattle, with additional operations in Hamilton, Mont., and
South San Francisco. |
|
 |
|
|
|
|
